Thank you, Roy, and good morning, everyone. We are very pleased to have delivered another year of consistent operational financial performance. Our businesses continue to perform well, reflecting our focus on retail excellence. On the full year, revenue came in at $61 billion and adjusted earnings at more than $2.6 billion. We delivered improving sales momentum, stable gross margin, and carefully managed our expenses while once again delivering strong earnings performance. In 2024, we repurchased $1.8 billion worth of our shares and increased our dividend per share by 13.9%. We also accelerated capital investments in our stores, adding 52 new food and drug retail stores and 78 pharmacy care clinics, representing 1.1% of square footage growth. We're already seeing a meaningful lift to our absolute sales from these stores. As we announced on Tuesday, we plan to reinvest over $10 billion back into the Canadian economy over the next five years, improving access to affordable food and healthcare services and creating jobs in communities across Canada. This includes opening another 80 stores and approximately 100 pharmacist care clinics in 2025. Turning to the quarter, we continue to see growing momentum across our businesses. On a consolidated basis, revenue growth was solid at 2.9%, reaching $14.9 billion, and adjusted EBITDA increased by 4%. Consolidated revenue and same-store sales were positively impacted by the shift in Thanksgiving, which occurred in Q4 this year compared to Q3 last year. Our sales performance in food improved even when adjusting for this shift and improved from Q3. Adjusted diluted net earnings per share grew by 10% to $2.20. On a GAAP basis, our net earnings decreased by 14.6%, primarily driven by a non-cash charge of $129 million related to the revaluation of our existing PC Optimum program liability. This nonrecurring charge reflects the fact that customer engagement with our popular PC Optimum program is increasing, leading to higher redemption rates in our stores in recent years. We increased this liability based on our expectation that more customers will redeem more of their PCO points going forward, reflecting the long-term success of our program. In food retail, we attracted higher customer traffic and drove tonnage growth. Absolute sales grew 3.7%. Our reported same-store sales increased 2.5%. As previously mentioned, the Thanksgiving shift, our right-hand side performance, and the elimination of multibuys all impacted our same-store sales. Our adjusted same-store sales growth was up 2% in the quarter. Canada's gross retail CPI was 2.4% in the quarter. Our internal CPI-like food inflation measure was lower than CPI this quarter. But also looking at our average article price data, which reflects the full basket mix bought by our customers, our internal inflation rate was much lower than CPI. Looking ahead, we're still seeing higher than normal pricing increases coming in from our larger global vendors, and many are requesting double-digit price increases. We continue to push back to mitigate these increases. This is compounded by the fact that we are working with a Canadian dollar that trades at the lowest level in over 20 years. A year ago, the Canadian dollar traded at 74 cents US, and we began Q4 at that level. But since our dollar has declined by 5% to 70 cents, this adds further inflationary pressure at a time when Canada relies on US imports for most of its fresh produce. We see consumers continuing to favor discount offerings. This is clearly demonstrated in our hard discounts banner same-store sale performance, which is outperforming our conventional stores. We recorded double-digit growth in absolute sales across our discount network in Q4 and in TNT Canada. TNT Canada is our fastest-growing banner. While the gap between hard discount and conventional has stabilized, growth in hard discount continues to be significantly higher than conventional. Last year, we added 58 hard discount stores to our network through conversions and new builds. These stores continue to resonate well with Canadians, driving strong performance. Q4 was a particularly busy quarter for our teams. We opened 26 new grocery stores, including our first TNT supermarket in Seattle, Washington. In Q4, we also concluded our network optimization initiative in Quebec. We now have 187 hard discount Maxi stores in Quebec, leading to market share growth in that province. Going forward, we will continue to expand our hard discount presence by adding approximately 50 new stores across the country in 2025, bringing more quality and value to more communities across Canada. Hard discount is still gaining tonnage market share, and our conventional stores are performing well. In drug retail, absolute sales increased 1.3% and same-store sales grew 1.3%. Pharmacy and healthcare services grew same-store sales by 6.3% again this quarter, driven by broad strength in prescription and new healthcare services. Our specialty acute and chronic prescription growth led our pharmacy numbers. Patients continue to respond very positively to the convenience and expanded level of primary care we offer to our more than 1,800 pharmacies across the country, including our 152 new in-store clinics. Our front store same-store sales declined 3.1%, primarily driven by the month-long Canada Post strike and our decision to exit electronics categories. We see ongoing pressure in convenience categories like food and household items. That said, we have continued strength in prestige beauty. Cough and cold was also weaker than planned, largely driven by a mild fall. Looking ahead, our decision to exit certain low-margin electronics categories such as laptops, computers, TVs, cameras, and games and consoles will have about a 1% impact on front store sales in 2025. That said, we remain pleased by the underlying strength, profitability, and sales momentum of Shoppers Drug Mart's front store business. Online sales in the quarter increased by 18.4%, carrying on our momentum from Q3. Within grocery, delivery continues to outperform as a channel. We remain pleased with our online sales penetration in both food and pharmacy. Full-year sales grew at 16.9% to $3.9 billion, and our food panacea penetration rate increased slightly. Across our grocery and pharmacy banners, we are proud to see Canadians increasingly choosing our stores for value, quality, service, and convenience. Total retail gross margin was 30.9%, down 20 basis points. The decline was mainly driven by sales mix, the impact of the closure of postal services during the Canada Post strike, and the Thanksgiving shift, partially offset by improvements in shrink this quarter. I'm pleased with the strong shrink improvements in both food and drug this past year. Food is now back to 2020 shrink rates, but we still have work to do across our pharmacies. Turning to SG&A, our spend rate as a percentage of sales improved by 20 basis points, driven by the lapping of prior year labor costs, including expenses related to the ratification of union labor agreements and some operating leverage. This was partially offset by incremental costs related to the ramp-up of new stores and conversions. Fourth-quarter retail EBITDA increased by $47 million, yielding a margin of 0.8%. PC Financial's revenue decreased 2.3%, driven by lower services growth in our mobile shop, which was partially offset by growth in the credit card portfolio. The bank's adjusted earnings before tax increased by $20 million, with higher interchange and credit card fee income, lower operating costs, and a positive year-over-year impact to the ECL provisions, offsetting the lapping of benefits associated with the renewal of a long-term agreement with Mastercard. We remain very comfortable with the risk profile of the bank's portfolio. We continue to take a conservative position in our provisioning with a strong and well-capitalized balance sheet. On a consolidated basis, adjusted EBITDA increased by 4% to $1.7 billion. Our retail free cash flow was $828 million, and we repurchased $352 million worth of common shares. On a full-year basis, our retail free cash flow was $1.5 billion. We grew our common share dividend by 13.9%, and we repurchased $1.8 billion worth of common shares. Our balance sheet remains strong, and we continue to improve our key return metrics. Our return on equity sits at 23.6%, and our return on capital at 11.8%. Looking ahead to 2025, we have a solid plan in place to keep on delivering consistent financial and operational performance while advancing our growth initiatives. We plan to open approximately 50 hard discount stores, approximately 30 Shoppers Drug Mart, and two TNT in 2025, bringing quality, value, service, and convenience to our customers. These new stores will grow our retail square footage by less than 2%. This year, we will also begin migrating operations to our new 1.2 million square feet fully automated distribution center in East Guillenborough, Ontario. This facility will further enhance our best-in-class supply chain, delivering efficiencies once fully operational. Please note that in 2025, we will have an extra week. We estimate that the resulting incremental impact on our EPS will be approximately 2% for the full year. Excluding the benefit of the extra week, we expect our retail business to grow earnings faster than sales and adjusted earnings per share growth in the high single digits. We plan to invest approximately $2.2 billion in capital expenditures and $1.9 billion net of proceeds from planned property disposal. Again, we plan to return most of our free cash flow to shareholders through dividends and share buybacks. We begin the new year encouraged by our early results in Q1. Same-store sales in both food and drug retail are off to a strong start, including positive same-store sales growth in shoppers' stores. Looking ahead, our focus on retail excellence and on the execution of our strategic initiatives will allow us to keep on delivering value to our customers and strong performance to our shareholders and sets us up well for the future. I will now turn the call over to Per.